High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

1. Montemuiño, S.
2. Dios, N.R.D.
3. Martín, M.
4. Taboada, B.
5. Calvo-Crespo, P.
6. Samper-Ots, M.P.
7. López-Guerra, J.L.
8. López-Mata, M.
9. Jové-Teixidó, J.
10. Díaz-Díaz, V.
11. Ingunza-Barón, L.D.
12. Murcia-Mejía, M.
13. Chust, M.
14. García-Cañibano, T.
15. Couselo, M.L.
16. Puertas, M.M.
17. Cerro, E.D.
18. Moradiellos, J.
19. Amor, S.
20. Varela, A.
21. Thuissard, I.J.
22. Sanz-Rosa, D.
23. Couñago, F.